tiprankstipranks
Kura Oncology (KURA)
NASDAQ:KURA

Kura Oncology (KURA) Financial Statements

477 Followers

Kura Oncology Financial Overview

Kura Oncology's market cap is currently ―. The company's EPS TTM is $-2.175; its P/E ratio is -9.63; Kura Oncology is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -49.13M-$ -38.20M$ -36.79M$ -31.57M
EBITDA$ -48.89M-$ -40.75M$ -38.56M$ -32.94M
Net Income Common Stockholders$ -49.52M$ -42.79M$ -38.60M$ -37.17M$ -31.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 527.12M$ 423.96M$ 452.59M$ 476.98M$ 405.90M
Total Assets$ 553.91M$ 448.94M$ 473.77M$ 494.74M$ 423.61M
Total Debt$ 16.97M$ 17.20M$ 17.42M$ 13.04M$ 13.54M
Net Debt$ -510.15M$ -406.76M$ -435.17M$ -463.94M$ -392.36M
Total Liabilities$ 48.82M$ 51.66M$ 43.83M$ 35.06M$ 30.79M
Stockholders Equity$ 505.08M$ 397.27M$ 429.94M$ 459.68M$ 395.18M
Cash Flow-
Free Cash Flow$ -48.93M-$ -29.05M$ -25.71M$ -35.91M
Operating Cash Flow$ -48.84M$ -34.31M$ -29.03M$ -25.62M$ -35.87M
Investing Cash Flow$ -95.34M$ 42.20M$ 8.56M$ -46.33M$ 11.13M
Financing Cash Flow$ 148.37M$ 691.00K$ 84.00K$ 94.01M-
Currency in USD

Kura Oncology Earnings and Revenue History

Kura Oncology Debt to Assets

Kura Oncology Cash Flow

Kura Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis